CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$43,000
-60.9%
37,474
-23.1%
0.00%
Q4 2021$110,000
-31.7%
48,710
+3.3%
0.00%
Q3 2021$161,000
-55.5%
47,164
-61.0%
0.00%
Q2 2021$362,000
+13.5%
121,015
+22.5%
0.00%
-100.0%
Q1 2017$319,000
+134.6%
98,777
-2.3%
0.00%
Q4 2016$136,000
-16.0%
101,077
-2.8%
0.00%
Q3 2016$162,000
+19.1%
103,977
+1.8%
0.00%
Q2 2016$136,000
-75.1%
102,177
-1.6%
0.00%
-100.0%
Q1 2016$547,000
-23.3%
103,877
+14.3%
0.00%
-50.0%
Q4 2015$713,000
-5.4%
90,891
+1.8%
0.00%0.0%
Q3 2015$754,000
-23.1%
89,269
-0.3%
0.00%0.0%
Q2 2015$981,000
-21.1%
89,569
+0.7%
0.00%
-33.3%
Q1 2015$1,244,000
-18.2%
88,965
-1.1%
0.00%
-25.0%
Q4 2014$1,520,000
+26.5%
89,965
+0.4%
0.00%
+33.3%
Q3 2014$1,202,000
+6.4%
89,582
+1.0%
0.00%0.0%
Q2 2014$1,130,000
+9.2%
88,673
+1.8%
0.00%0.0%
Q1 2014$1,035,000
-13.5%
87,073
+0.5%
0.00%0.0%
Q4 2013$1,197,000
-20.3%
86,673
+0.7%
0.00%
-25.0%
Q3 2013$1,502,000
+10.8%
86,073
+3.2%
0.00%0.0%
Q2 2013$1,356,000
-46.0%
83,429
+61.0%
0.00%
-50.0%
Q1 2013$2,512,00051,8180.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 17,426,968$36,945,0001.45%
Opaleye Management Inc. 3,171,800$6,724,0000.88%
EAM Investors, LLC 421,103$893,0000.15%
Bleichroeder LP 250,000$530,0000.10%
PLATINUM INVESTMENT MANAGEMENT LTD 755,593$1,602,0000.04%
Callan Capital, LLC 73,200$155,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 419,300$889,0000.02%
Private Wealth Advisors, Inc. 12,000$25,0000.01%
Alpine Global Management, LLC 24,575$52,0000.01%
Evercore Wealth Management, LLC 143,138$303,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders